Park J, Lee T, Ha K, Ki C
Orphanet J Rare Dis. 2021; 16(1):166.
PMID: 33836803
PMC: 8033735.
DOI: 10.1186/s13023-021-01789-2.
Prosnitz A, Leopold J, Irons M, Jenkins K, Roberts A
Congenit Heart Dis. 2017; 12(4):475-483.
PMID: 28719049
PMC: 5825182.
DOI: 10.1111/chd.12471.
Wassif C, Kratz L, Sparks S, Wheeler C, Bianconi S, Gropman A
Genet Med. 2016; 19(3):297-305.
PMID: 27513191
PMC: 5303568.
DOI: 10.1038/gim.2016.102.
Bianconi S, Cross J, Wassif C, Porter F
Expert Opin Orphan Drugs. 2015; 3(3):267-280.
PMID: 25734025
PMC: 4343216.
DOI: 10.1517/21678707.2015.1014472.
Ying L, Matabosch X, Serra M, Watson B, Shackleton C, Watson G
Mol Genet Metab Rep. 2014; 1:103-113.
PMID: 25024934
PMC: 4093838.
DOI: 10.1016/j.ymgmr.2014.02.002.
Challenging behavior in Smith-Lemli-Opitz syndrome: initial test of biobehavioral influences.
Freeman K, Eagle R, Merkens L, Sikora D, Pettit-Kekel K, Nguyen-Driver M
Cogn Behav Neurol. 2013; 26(1):23-9.
PMID: 23538569
PMC: 3684260.
DOI: 10.1097/WNN.0b013e31828bf6d5.
Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome.
Olah A, Szabo G, Varga J, Balogh L, Csabi G, Csakvary V
Eur J Pediatr. 2013; 172(5):623-30.
PMID: 23319240
DOI: 10.1007/s00431-012-1925-z.
Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.
Svoboda M, Christie J, Eroglu Y, Freeman K, Steiner R
Am J Med Genet C Semin Med Genet. 2012; 160C(4):285-94.
PMID: 23042642
PMC: 3890258.
DOI: 10.1002/ajmg.c.31347.
Growth charts for individuals with Smith-Lemli-Opitz syndrome.
Lee R, McGready J, Conley S, Yanjanin N, Nowaczyk M, Porter F
Am J Med Genet A. 2012; 158A(11):2707-13.
PMID: 22615010
PMC: 3427420.
DOI: 10.1002/ajmg.a.35376.
Malformation syndromes caused by disorders of cholesterol synthesis.
Porter F, Herman G
J Lipid Res. 2010; 52(1):6-34.
PMID: 20929975
PMC: 2999931.
DOI: 10.1194/jlr.R009548.
A novel DHCR7 mutation in a Smith-Lemli-Opitz syndrome infant presenting with neonatal cholestasis.
Ko J, Choi B, Seo J, Shin J, Chae J, Kang G
J Korean Med Sci. 2010; 25(1):159-62.
PMID: 20052364
PMC: 2799999.
DOI: 10.3346/jkms.2010.25.1.159.
Molecular screening of Smith-Lemli-Opitz syndrome in pregnant women from the Czech Republic.
Blahakova I, Makaturova E, Kotrbova L, Soukupova M, Lastuvkova J, Kozak L
J Inherit Metab Dis. 2007; 30(6):964-9.
PMID: 17994283
DOI: 10.1007/s10545-007-0710-z.
R352Q mutation of the DHCR7 gene is common among Japanese Smith-Lemli-Opitz syndrome patients.
Matsumoto Y, Morishima K, Honda A, Watabe S, Yamamoto M, Hara M
J Hum Genet. 2005; 50(7):353-356.
PMID: 16044199
DOI: 10.1007/s10038-005-0267-3.
The Smith-Lemli-Opitz syndrome.
Kelley R, Hennekam R
J Med Genet. 2000; 37(5):321-35.
PMID: 10807690
PMC: 1734573.
DOI: 10.1136/jmg.37.5.321.
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.
Witsch-Baumgartner M, Fitzky B, Ogorelkova M, Kraft H, Moebius F, Glossmann H
Am J Hum Genet. 2000; 66(2):402-12.
PMID: 10677299
PMC: 1288092.
DOI: 10.1086/302760.
Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation.
Nowaczyk M, Whelan D, Heshka T, Hill R
CMAJ. 1999; 161(2):165-70.
PMID: 10439827
PMC: 1230468.
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.
Waterham H, Wijburg F, Hennekam R, Vreken P, Poll-The B, Dorland L
Am J Hum Genet. 1998; 63(2):329-38.
PMID: 9683613
PMC: 1377322.
DOI: 10.1086/301982.
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.
Ryan A, Bartlett K, Clayton P, Eaton S, Mills L, Donnai D
J Med Genet. 1998; 35(7):558-65.
PMID: 9678700
PMC: 1051366.
DOI: 10.1136/jmg.35.7.558.
Disorders of cholesterol biosynthesis.
Clayton P
Arch Dis Child. 1998; 78(2):185-9.
PMID: 9579167
PMC: 1717457.
DOI: 10.1136/adc.78.2.185.
Molecular cloning and expression of the human delta7-sterol reductase.
Moebius F, Fitzky B, Lee J, Paik Y, Glossmann H
Proc Natl Acad Sci U S A. 1998; 95(4):1899-902.
PMID: 9465114
PMC: 19210.
DOI: 10.1073/pnas.95.4.1899.
